Il suffit parfois d’un soutien pour avancer avec la maladie. Les aidants jouent un rôle essentiel auprès des patients atteints de sclérose en plaques. Ils apportent un soutien moral : ils réconfortent, rassurent, encouragent, apaisent. C’est fréquemment le premier confident du patient. L’aidant intervient aussi souvent dans la vie quotidienne : tâches ménagères, préparation des repas, courses et dossiers administratifs liés à la maladie.
Acupressure is a therapy method performed with an instrument or hand, fingertip, palm, elbow, knee, thumb relaxation and wrist bands on various points representing the waist organs in order to ensure the continuation and balance of the energy in our body.
Multiple sclerosis (MS) sufferers may develop a disabling condition severe enough to prevent them from continuing in employment or returning to work after a relapse. If as a MS sufferer you face permanent restrictions on being able to work you may be eligible for a social security disability benefit from the Social Security Administration (SSA).
The researchers found that compared with controls without autoimmune disease, 43 ICD-10 codes were recorded more frequently for patients with MS before diagnosis. In comparison to the other control groups, many of these findings were confirmed. A high proportion of these codes represent symptoms indicative of demyelinating events or other neurologic diseases.
Multiple sclerosis (MS) results in considerable financial burdens due to expensive treatment and high rates of disability, which could both impact care non-adherence.
MS patients with lower financial self-efficacy and prior relapse history are at higher risk for financial toxicity, with associated care non-adherence and lower HRQOL.
Multiple sclerosis, or MS, is a complex, chronic disease that affects the central nervous system. If you or someone you love has recently been diagnosed with multiple sclerosis, the first step you can take in effectively managing your condition is to learn everything you can about your diagnosis. Ask your provider if he or she has any informational pamphlets about MS, check out organizations like the National MS Society, or read below for a primer on what exactly MS is and how it’s diagnosed.
Multiple sclerosis (MS) is an autoimmune disease in which the body's immune system attacks its own central nervous system (the brain and spinal cord). In MS, the immune system attacks and damages or destroys myelin, a substance that surrounds and insulates the nerves. The myelin destruction causes a distortion or interruption in nerve impulses traveling to and from the brain. This can result in a wide variety of symptoms.
BrainStorm Cell Therapeutics has presented phase 2 data on its stem cell therapy in patients with multiple sclerosis (MS). The small, open-label clinical trial linked autologous therapy NurOwn to a 25% improvement in measures of mobility and dexterity in around 14% of patients.
Damage to the brain gray matter plays an important role in the progression of multiple sclerosis. This study now shows that such damage can be caused by inflammatory reactions that lead to loss of synapses, which impairs neural activity.
The new vaccine technology mRNA is making waves these days as COVID-19 shots based on it deliver efficacy that’s unrivaled by other platforms. One of the successful shots, Comirnaty (BNT162b2), was developed with BioNTech’s technology and is being rolled out in the U.S. and EU.
Que fait un ergothérapeute ? Qu'est ce que la myéline ? Retrouvez ici toutes les définitions pour mieux comprendre le vocabulaire médical autour de votre SEP.
Motor rehabilitation using virtual reality (VR) may improve hand and arm function in people with multiple sclerosis (MS), according to a review study. Evidence of its beneficial effect is, however, still preliminary, as most analyzed studies included small patient groups and some failed to show statistically significant improvements in upper limb function, the researchers noted.
Multiple Sclerosis (MS) is one of the leading causes of non-traumatic neurological disability among young adults. Due to its complex pathology and the lack of reliable disease models, there are no effective therapies for MS to prevent neurodegeneration or promote neuroprotection, and hence stop disease progression. The emergence of induced pluripotent stem cells (iPSC) has allowed the generation of patient-specific neural cell types for disease modelling, drug screening, and cell therapy.
As one of the world’s most common neurological disorders, multiple sclerosis (MS) is a growing cause for concern. The disease affects the central nervous system, i.e. the brain, spinal cord, and optic nerves in the body, which can lead to a variety of problems. While there is no known cure for the condition, the latest research suggests that an early diagnosis can benefit patients greatly. With that in mind, here are some of the early signs of MS you should look out for.
Because existing MS therapeutics suppress the immune system in a systemic way, scientists have been trying to find alternative therapies that target the disease in an antigen-specific way. This approach requires understanding which myelin self-antigens are involved in MS. Problem is, disease-causing antigens can differ among patients or change over time in the same patient.
For decades, multiple sclerosis (MS) has been depicted as a disease of the immune system running amok and attacking the whitish myelin sheath that encases the axons of the neurons in the central nervous system. The myelin is commonly analogized to insulation of electrical wiring; once compromised, the signals traveling through those axons get garbled and people with MS experience a range of neurological symptoms. In this telling, directionally MS is an “outside-in” condition of the immune system compromising the central nervous system. But there is a camp of MS researchers who want to flip the narrative — or at least get their version considered — and have MS viewed as an “inside-out” phenomenon starting inside the central nervous system and resulting in secondary inflammation.
The companies will use a combination of more than seven years of medical record data with five years of prospective data on 5,000 MS patients, including real-world outcomes data and MRI images. Other disease areas to be explored include hematology and rare diseases.
A medical student, Alex was diagnosed with multiple sclerosis more than 2 years ago and was distressed to learn that he had the aggressive form of MS and was on track to be in a wheelchair in a matter of months.
The identification of progression in multiple sclerosis is typically retrospective. Given the profound burden of progressive multiple sclerosis, and the recent development of effective treatments for these patients, there is a need to establish measures capable of identifying progressive multiple sclerosis early in the disease course. Starting from recent pathological findings, this review assesses the state‐of‐the‐art of potential measures able to predict progressive multiple sclerosis.
A Mandell Center team examines how MS-related pain impacts patients’ ability to carry out activities away from home. Plus, how cognitive strategies and family support may make a difference.
It has been about 3 months since I last updated you on Preston Walker and Richard Humphries, the two Multiple Sclerosis Stem Cell Research pioneers who received their own Adult Stem Cells to improve their MS. Since then, both have returned to Costa Rica to receive a second helping of their own Adult Stem Cells- a second stem cell therapy. Let’s check in with their stem cell blog and see what they have to say.
A blood test may help predict which people with multiple sclerosis will get worse during the following year, according to a new study. The blood test looks for a biomarker called neurofilament light chain, a nerve protein that can be detected in the blood when nerve cells die.
Results from a study presented at the 2020 Consortium of Multiple Sclerosis Centers (CMSC) Virtual Annual Meeting suggest that the use of aerobic fitness has a positive effect on physical and cognitive function in older adults with multiple sclerosis (MS) and may be used as an approach to ameliorate the consequences of aging.
To provide clinicians who treat multiple sclerosis (MS) patients with evidence-based or expert opinion–based recommendations for promoting exercise and lifestyle physical activity across disability levels.
Symptoms of the condition vary widely and primarily depends upon which nerves are affected and the amount of damage caused. Those who have severe MS may lose the ability to independently walk while others may suffer from remissions for longer periods without showing any new symptoms.
Multiple sclerosis
